Acute severe childhood asthma by M. Levin, E. Weinberg

Get full text

Dynamics of the Antioxidant System and Endogenous Intoxication in Patients Being Treated for Microbial Eczema by М. M. Tlish, Е. К. Popandopulo

“…The paper studies the dynamics of the indicators defi ning the antioxidant system (AOS) and endogenous intoxication in patients with microbial eczema (ME) prior to and following treatment.Materials and methods. …”
Get full text

Kaposi Varicelliform Eruption Complicated by Steroids: A Case Report and Review of Literature by Aniket Goswami, Shikha Verma, Chingshubam Bikash, Pranjal Kalita

Get full text

Generalization of the clinical experience of usе a combined drug in the form of a cream for topical application in the complex therapy of patients with chronic dermatoses by N. V. Kungurov, M. M. Kokhan, Yu. V. Keniksfest, I. A. Kuklin, O. G. Rimar, Ya. V. Kascheeva, E. I. Stukova

“…Monitoring of these groups of patients established regression of EASI indices, the severity index of pyogenic manifestations, the severity index of bullous dermatoses by more than 75.0% from the baseline in the period from 7 to 14 or 21 days of therapy, which corresponded to the clinical remission within the inpatient stage of treatment. …”
Get full text

Pretreatment Demodex infestation predicts dupilumab-associated blepharoconjunctivitis in atopic dermatitis by Paulina Stepinska, Kamila Zawadzinska-Halat, Maciej Pastuszczak

“…Baseline Demodex infestation was significantly more frequent in the DAOSD group (70.0% vs. 5.0%; p = .0004; OR = 44.3). Baseline Eczema Area and Severity Index (EASI) scores, IgE levels, and Schirmer results did not differ. …”
Get full text

The Role of Vitamin D in Allergic Diseases by Joanna Maria Szydziak, Aleksandra Hrapkowicz, Kinga Janowska, Daria Dąbkowska, Olga Szeidl, Dominika Rehan, Julia Wołoszczak, Agnieszka Mioskowska

“…Conversely, supplementation may help prevent allergies, reduce the severity of atopic dermatitis by supporting skin barrier function and antimicrobial peptide production, and relieve symptoms in patients with chronic urticaria.             …”
Get full text

The real-world burden of atopic dermatitis: MEASURE-AD results from Brazil, Mexico, and Argentina by Catalina Rincón Pérez, Valeria Aoki, Roberta F. Criado, Martti Antila, Maria Valeria Angles, Tania Ferreira Cestari, Delfina Guadalupe Villanueva Quintero, Gabriel Magariños, Carla Castro, Adriana López Tello-Santillán, Magda Weber, Daniel Lorenzini, Caio Cesar Silva de Castro, Jorge Maspero, Linda García-Hidalgo, Limei Zhou, Shereen Hammad, Lucila de Campos, Tatiane Cristina Rodrigues, Carolina Arzelán, Paula C. Luna

“…A very/extremely large effect on QoL (DLQI/CDLQI ≥ 11) was reported among 50.0% of patients ≥ 16 years old and 42.9% of patients 12-15 years old. The mean Eczema Area Severity Index (EASI) was 17.0 (adults, 17.7; adolescents, 12.4); 3.9% of patients had clear skin (EASI 0) and 26.7% had severe AD (EASI 23-72). …”
Get full text

Real-World Clinical Experience of Tralokinumab in a Tertiary Centre: An Alternative for Patients with Conjunctivitis on Dupilumab? by Neenu Sebastian, Omar Chircop, Tim H. Clayton, Firas C. Kreeshan, Hamish J. A. Hunter, Richard B. Warren

“…Methods This retrospective study reviewed the Eczema Area and Severity Index (EASI) and Dermatology Life Quality Index (DLQI) at baseline and 16–20 weeks of 39 consecutive patients who received subcutaneous tralokinumab at the label dose in a tertiary centre. …”
Get full text

An integrated deep learning framework using adaptive enhanced vision fusion and modified mobilenet architecture for precision classification of skin diseases with enhanced diagnost... by Ahsan Bilal Tariq, Muhammad Zaheer Sajid, Nauman Ali khan, Muhammad Fareed Hamid, Anwaar UlHaq, Jarrar Amjad

“…Dermo-Transfer was trained on 77,314 images covering skin conditions such as molluscum, warts, eczema, psoriasis, lichen planus, seborrheic keratoses, atopic dermatitis, melanoma, basal cell carcinoma (BCC), melanocytic nevi (NV), benign keratosis, and other benign tumors. …”
Get full text

Protein hydrolysate and soy-based formula in dietary management for children allergic to cow’s milk proteins: criteria for choice by S. G. Gribakin, A. G. Timofeeva, O. A. Bokovskaya

“…CMPA is usually characterized by skin manifestations, gastrointestinal symptoms or in a mixed form. Atopic eczema performs with skin manifestation. Breast feeding is the best strategy for allergy prevention. …”
Get full text

Tapinarof Cream for Adults and Children with Atopic Dermatitis—Efficacy by Race and Fitzpatrick Skin Type in Two Phase 3 Randomized Clinical Trials by Andrew F. Alexis, Leon Kircik, Raj Chovatiya, Zakiya P. Rice, Weily Soong, Tina Bhutani, Philip M. Brown, Stephen C. Piscitelli, David S. Rubenstein, Anna M. Tallman, April W. Armstrong

“…Secondary endpoints included achieving ≥ 75% improvement in Eczema Area and Severity Index (EASI75). Efficacy evaluations used race categories of Asian, Black or African American, and white, and Fitzpatrick skin types I–III and IV–VI. …”
Get full text

Protocol for a double-blinded randomised controlled trial and process evaluation of a digital psychotherapeutic app in Singapore to improve symptom burden in patients with dermatol... by Nick Sevdalis, Jose M Valderas, Valencia Long, Mark Jean-Aan Koh, Liang Shen, Phillip Phan, Ellie Choi, Nisha Suyien Chandran, Mayank Dalakoti, Ziying Vanessa Lim, Jia Yi Chua, Cyrus S Ho, Kean J Hsu

“…Up to 80% of patients with dermatological conditions experience severe itch and poor sleep, as well as related mental health challenges such as anxiety and depression. …”
Get full text

Melatonin - A Cutaneous Perspective by Tapan Dhali, Mona Sharma, Priyanka Hemrajani

“…Melatonin may play a role in treating several dermatoses e.g., atopic eczema, psoriasis, melasma, ulcer healing, and malignant melanoma. …”
Get full text

Melatonin - A Cutaneous Perspective by Tapan Dhali, Mona Sharma, Priyanka Hemrajani

“…Melatonin may play a role in treating several dermatoses e.g., atopic eczema, psoriasis, melasma, ulcer healing, and malignant melanoma. …”
Get full text

Non-FDA-Approved Uses of Apremilast in Dermatology: A Review of Current Available literature by Saurabh Bhatia

“…Individual case series and reports were found for Acrodermatitis Continua of Hallopeau, Dermatomyositis, Disseminated Granuloma Annulare, Erythema Nodosum Leprosum, Morphea, Pityriasis Rubra Pilaris, Hailey-Hailey Disease, Recurrent Erythema Multiforme, and Folliculitis Decalvans, Prurigo Nodularis, Perforating Dermatoses, Chronic Actinic Dermatitis, and Hand Eczema, and Epidermolysis Bullosa Simplex-Generalised Severe Type. …”
Get full text

Non-FDA-Approved Uses of Apremilast in Dermatology: A Review of Current Available literature by Saurabh Bhatia

“…Individual case series and reports were found for Acrodermatitis Continua of Hallopeau, Dermatomyositis, Disseminated Granuloma Annulare, Erythema Nodosum Leprosum, Morphea, Pityriasis Rubra Pilaris, Hailey-Hailey Disease, Recurrent Erythema Multiforme, and Folliculitis Decalvans, Prurigo Nodularis, Perforating Dermatoses, Chronic Actinic Dermatitis, and Hand Eczema, and Epidermolysis Bullosa Simplex-Generalised Severe Type. …”
Get full text